Peeter Karihtala

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 134 publications

CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study.

CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study.

Journal: Journal of geriatric oncology

Published: November 25, 2025

Insights on postneoadjuvant treatment among patients with triple-negative breast cancer and residual disease after neoadjuvant therapy: can expert consensus help to interpret the current evidence?

Insights on postneoadjuvant treatment among patients with triple-negative breast cancer and residual disease after neoadjuvant therapy: can expert consensus help to interpret the current evidence?

Journal: British journal of cancer

Published: November 02, 2025

Real-world outcome of neoadjuvant therapy with or without pembrolizumab for triple-negative breast cancer.

Real-world outcome of neoadjuvant therapy with or without pembrolizumab for triple-negative breast cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: October 14, 2025

Real-world outcome of neoadjuvant therapy with or without pembrolizumab for triple-negative breast cancer.

Real-world outcome of neoadjuvant therapy with or without pembrolizumab for triple-negative breast cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: October 14, 2025

Gut microbiota-derived extracellular vesicles form a distinct entity from gut microbiota.

Gut microbiota-derived extracellular vesicles form a distinct entity from gut microbiota.

Journal: mSystems

Published: April 29, 2025

Impact of the COVID-19 pandemic on the quality of life of early breast cancer patients undergoing adjuvant chemotherapy - an observational, multicenter study.

Impact of the COVID-19 pandemic on the quality of life of early breast cancer patients undergoing adjuvant chemotherapy - an observational, multicenter study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: April 23, 2025

How to choose optimal adjuvant therapies for high-risk hormone receptor-positive, HER2-negative breast cancer after chemotherapy?

How to choose optimal adjuvant therapies for high-risk hormone receptor-positive, HER2-negative breast cancer after chemotherapy?

Journal: Acta oncologica (Stockholm, Sweden)

Published: April 16, 2025

The metabolome of fecal extracellular vesicles in patients with malignant solid tumors.

The metabolome of fecal extracellular vesicles in patients with malignant solid tumors.

Journal: Scientific reports

Published: March 28, 2025

Plasma proteomics to explore benefit from anti-PD-(L)1 in advanced solid tumors: a prospective pilot study.

Plasma proteomics to explore benefit from anti-PD-(L)1 in advanced solid tumors: a prospective pilot study.

Journal: Scientific reports

Published: March 04, 2025

Metastatic triple-negative breast cancer - current treatment strategies in the Nordics: a modified Delphi study.

Metastatic triple-negative breast cancer - current treatment strategies in the Nordics: a modified Delphi study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: December 15, 2024

Medical students' knowledge on palliative care - a survey of teaching in Finland.

Medical students' knowledge on palliative care - a survey of teaching in Finland.

Journal: MedEdPublish (2016)

Published: November 20, 2024

Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients.

Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients.

Journal: Future oncology (London, England)

Published: October 21, 2024

Showing 1-12 of 134

Last Updated: 09/26/2026